SIM0532

N/A

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameSIM0532
Drug Alias NameSIM-0532SIM0532
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGTPase Ras modulators
TargetsGTPase Ras
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Simcere Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Xianwei Pharmaceutical Technology Co LtdNanjing Simcere Dongyuan Pharmaceutical Co Ltd
Inactive CompaniesJiangsu Simcere Pharmaceutical Co Ltd
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A